Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

GLP-1 Muscle Preservation: Treatment Comparison

GLP-1 monotherapy (no intervention) Appetite suppression → caloric deficit 0.8–1.0g/kg (typical intake) None 60–75% Achieves weight loss but loses significant muscle. Metabolic rate drops, rebound risk increases GLP-1 + protein supplementation Appetite suppres

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • GLP-1 monotherapy (no intervention)
  • Appetite suppression → caloric deficit
  • 0.8–1.0g/kg (typical intake)
  • None
  • 60–75%
  • Achieves weight loss but loses significant muscle. Metabolic rate drops, rebound risk increases
  • GLP-1 + protein supplementation
  • Appetite suppression + leucine threshold maintenance
  • 1.6–2.2g/kg distributed across meals
  • 70–80%
  • Better than baseline but insufficient. Protein alone doesn't signal muscle retention
  • GLP-1 + resistance training
  • Appetite suppression + mechanical stimulus for muscle preservation
  • 3x/week progressive overload
  • 75–85%
  • Training signals retention but lacks substrate. MPS still compromised by low protein
  • GLP-1 + protein + resistance training
  • Appetite suppression + leucine threshold + mechanical stimulus
  • 1.6–2.2g/kg + resistance training 3x/week
  • 85–95%
  • Optimal strategy. Combines substrate availability with functional signal for muscle retention